We need DATA that they have and are holding. We need new investors at $10, not the forever longs who bought at .50, they are not factor now. Every day it is the same pump from the early investors who will hold and see where they are in five years or so. We need data better than P2 and it should be obvious to all of us by now. Dr. Kim has talked partnerships for a year and so far he is still in the talking stage with a pps in the twos, and a shrinking market cap. Getting ready to dilute and pressure on the pps keeps the big buyers on the sidelines for now. DATA does the job period. It puts big pharma under pressure to secure their place at the table and they will pony up big when the data is strong enough. All of you early buyers who will buy another 100 golden eggs do little for the current pps, we need the bigs now at $10. All the conference calls andpublic forums have done nothing for the pps so I am convinced it is DATA and only DATA that will bring new money into INO.
This board doesn't want to see anybody make a dime until they are making some too. Should be satisfied with their buys and profits and happy for the new investors who are not flying into INO at this point, but are becoming familiar with the company as they trade. All the financial manipulations by Dr. Kim has made this a trading stock and took all the zip out of it. Yes, it will be very successful as we go if data supports what we see so far, but come on folks, you gotta let other people make some money along the way. It ain't all about you early birds. We need new investors and the traders will become longs in time.
I haven't voted for the BOD in years due to their lack of investment in the company. Can't figure why they don't see their lack of interest as damaging the company and its investors.
They should have plenty of cash to get 1400 started why more dilution with the pps still at $2.50 pre RS? I was thinking dilution after some data to propel the pps more toward $15. On the surface it would appear that we lost 75% of our shares and gained nothing so far. The cash position he keeps talking about seems to come up short every three months or so.
into a trading stock. Don't think that was what Dr. Kim was looking for with the RS. Every up day is met with equal selling the next. Patterns are tough to break once established. News will do it and solid data will be even better. Here's hoping we get some today.
You're right and I have stated that many times. And it indicates Tokman"s knowledge of this science is a learn as you go process and he comes up very short when compared to projections by others who investigate his statements. The fact that we survived his many missteps is a miracle. Says a lot for the tech in my opinion.
Alec Tokman is keeping the stock down and has for the past ten years. Why doesn't anyone see that his management style has caused the distrust here in the market. No conspiracy, just poor management. If we're successful it will be because Sony realized the tech is the best and they can complete the development and supply the world with modules and lasers and be the go to company for laser projection. The only thing I credit Alex Tokman with is the fact that he kept this company going to get his paychecks regularly and kept the lights on when I thought we would of been long gone. I have been here a very long time and will stay to see the end of this movie and wish the longs good fortune as the shorts have had their day.
Right now the stock is worth about $10 a share and will not increase without data. A take over might happen when we prove the science and the pps will rise accordingly and that will give big pharma numbers to break down and make an offer. I am optimistic going forward that we have a great chance to see this worth $200 a share, but I am not kidding myself either, it is going to take really good numbers to get there, much better than the p2 numbers in July. In the meantime will have to depend on Dr. Kim and conferences to help keep us close to $10 and I see that as a challenge.